Brief report · 29 Dec 2025
Conference abstractPublished 15 Apr 2014
The use of biomarkers to characterize colorectal cancer: From genetic make-up to complex phenotypic measurement
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
M ajority of cancer cases occurs sporadically as a consequence of complex interplay between genetic variants and environmental factors. Colorectal carcinogenesis (CRC) involves a plethora of events, such as uncontrolled proliferation and genomic instability, which point to the DNA repair and DNA damage response as to the key players. Here we overview several biomarkers in mapping heterogenous complex disease, which poses a serious health problem worldwide, and provide an excursion into the DNA repair phenotypic reflection in control individuals and CRC patients. Gene variants involved in pathways, such as DNA repair, cell cycle control, folate metabolism and methylation, insulin resistance and obesity, ABC transporters, seleno proteins, inflammatory/immune response have shown various degree of association with CRC risk. Gene expression levels in relevant pathways were complemented with transcription regulations by methylation. Post-transcriptional regulation via miRNA or lncRNA was evaluated in relation to the CRC risk and the efficacy of chemotherapy. SNPs in miRNA binding sites of SMUG1 gene affect significantly survival in 5-fluorouracil-treated CRC patients, suggesting the importance of SNPs within miRNA-dependent regulatory regions. Expressions of the specific proteins (mismatch repair, base excision repair) were also assayed for. Functional DNA repair tests have been implemented as biomarkers of the complex phenotype. Multiple biomarkers, covering genetic, epigenetic and functional aspects, may define the phenotypic landscape of the disease and delineate the individual response to the therapy. Functional DNA repair assays reflect the capacity of the organism to cope with a chronic exposure to numerous environmental and dietary genotoxicants and may also be used as predictive markers in cancer therapy
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Molecular Biomarkers & Diagnosis.
Commentary · 29 Dec 2025
Molecular Diagnostics: Revolutionizing Precision Healthcare
Commentary · 29 Dec 2025
Genomic Biomarkers Revolutionizing Disease Diagnosis and Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Biomarkers & Diagnosis
- SubjectGenetics & Molecular Biology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “P. Vodicka”
- BylineArticles whose byline prints “J. Slyskova”
- BylineArticles whose byline prints “B. Pardini”
- BylineArticles whose byline prints “A. Naccarati”
- BylineArticles whose byline prints “L. Vodickova”
- BylineArticles whose byline prints “L. Bielik”
- BylineArticles whose byline prints “V. Polakova”
- BylineArticles whose byline prints “P. Prochazka”
